Piramal’s Supradyn: Illusory Vitality and Expensive Urine by DebaprasadBandyopadhyay Via Flickr: onceinabluemoon2021.in/2025/10/02/piramals-supradyn-illus... This communication critically examines Piramal Pharma’s over-the-counter multivitamin supplement Supradyn, highlighting concerns of pharmacological redundancy, cumulative risks, and misleading advertising. While promoted as a universal “energy booster,” Supradyn’s formulation—comprising multiple water- and fat-soluble vitamins, trace minerals, and herbal additives like ginseng—offers limited physiological benefit for healthy adults: water-soluble vitamins are largely excreted, fat-soluble vitamins and trace minerals may accumulate to toxic levels, and ginseng poses risks of insomnia, cardiovascular effects, drug interactions, and psychiatric destabilization. Evidence from Indian and global experts underscores that routine supplementation is unnecessary in non-deficient populations, and clinical trials consistently show minimal to no outcome benefit, contrary to perception-driven surveys like the EIGEN 2020 study. Piramal’s marketing strategies, which exploit fatigue, lifestyle anxieties, and survey-based claims, risk contravening the Drugs and Magic Remedies Act, Food Safety regulations, and ethical standards of pharmaceutical communication, while fine-print disclaimers fail to ensure informed consumer consent. The analogy with financial exploitation through DHFL underscores how trust is commodified in both finance and health, extracting costs under the guise of benefit. In light of public health ethics, global regulatory frameworks, and consumer safety, the letter urges Piramal Pharma and relevant authorities to adopt transparent labeling, evidence-based advertising, and stricter oversight, emphasizing diet-first strategies and targeted supplementation for clinically confirmed deficiencies rather than universal promotion of multivitamins.